[Expert recommendations 2006 on the rationale for second-line therapy for non-small cell bronchial neoplasms]

Wien Klin Wochenschr. 2007;119(7-8):259-66. doi: 10.1007/s00508-007-0792-5.
[Article in German]
No abstract available

Publication types

  • Review

MeSH terms

  • Antineoplastic Agents / administration & dosage*
  • Austria
  • Bronchial Neoplasms / drug therapy*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Practice Guidelines as Topic*
  • Societies, Medical*

Substances

  • Antineoplastic Agents